SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 16th, 2021 • Aravive, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledFebruary 16th, 2021 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”), dated as of February 12, 2021, is made by and between ARAVIVE, Inc., a Delaware corporation (the “Company”), and Eshelman Ventures, LLC, a North Carolina limited liability company (the “Purchaser”). The capitalized terms used herein and not otherwise defined have the meanings given them in Article 6.